Studies help shed light on aggressive brain cancer

Mutations affect how cancer starts in glial cells — brain cells that provide support and insulation for neurons — and how those mutations affect the way cancer evolves from low-grade gliomas to full-blown high-grade glioblastomas, the most common and deadly of primary brain cancer, shows a new study. A second study shows how using a combination of drugs at increased potency could prove an effective therapy against glioblastoma by inhibiting the PI3K and MAPK cellular pathways. (Mehr in: Cancer News — ScienceDaily)